MedTrace Logo

The Effect of Direct Cyclophotocoagulation Using Endolaser in Silicon Induced Glaucoma: a Pilot Study.

NCT05231252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-11-23

No results posted yet for this study

Summary

Transcleral cyclophotocoagulation has been used to treat glaucoma secondary to silicone oil

Conditions

Interventions

PROCEDURE

Cyclophotocoagulation

Transcleral cyclophotocoagulation is used to treat glaucoma secondary to silicone oil.

Sponsors & Collaborators

  • Kafrelsheikh University

    lead OTHER

Principal Investigators

  • Ahmed A.Mohamed, PhD · Ain Shams University,Faculty of medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-01-01
Completion
2022-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05231252 on ClinicalTrials.gov